CARTOX
Toxicity assessment tool
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
Cellular therapies can be associated with unique, acute toxicities which can be severe or even fatal if not identified early and treated appropriately.
Cytokine Release Syndrome (CRS), the most commonly observed toxicity can range in severity from low-grade constitutional symptoms to high-grade syndrome associated with life-threatening multi-organ disfunction. Neurotoxicity, originally termed CRES (CAR-Related Encephalopathy Syndrome) and now updated to ICANS (Immune effector Cell-Associated Neurotoxicity Syndrome) is the second most-common adverse even and can occur concurrently with CRS. A multi-disciplinary working group was formed to address safety issues for patients receiving cellular therapy which led to the development of new grading methods and treatment algorithms that have been incorporated into the CARTOX mobile app.
The CARTOX mobile app assists with grading toxicities, managing toxicities and assists with recommendations regarding appropriate antimicrobial prophylaxis for patients who have received immune effector cell therapy. Users are more easily able to determine if the patient is having cytokine release syndrome or neurotoxicity and to grade those toxicities.
Intended audience: Clinicians (physicians, nurse practitioners, physician assistants, pharmacists, nurses) who treat/care for patients receiving immune effector cells.
Hide..
Show more..
Cytokine Release Syndrome (CRS), the most commonly observed toxicity can range in severity from low-grade constitutional symptoms to high-grade syndrome associated with life-threatening multi-organ disfunction. Neurotoxicity, originally termed CRES (CAR-Related Encephalopathy Syndrome) and now updated to ICANS (Immune effector Cell-Associated Neurotoxicity Syndrome) is the second most-common adverse even and can occur concurrently with CRS. A multi-disciplinary working group was formed to address safety issues for patients receiving cellular therapy which led to the development of new grading methods and treatment algorithms that have been incorporated into the CARTOX mobile app.
The CARTOX mobile app assists with grading toxicities, managing toxicities and assists with recommendations regarding appropriate antimicrobial prophylaxis for patients who have received immune effector cell therapy. Users are more easily able to determine if the patient is having cytokine release syndrome or neurotoxicity and to grade those toxicities.
Intended audience: Clinicians (physicians, nurse practitioners, physician assistants, pharmacists, nurses) who treat/care for patients receiving immune effector cells.
Screenshots
User Rating
0 out of 5
0 ratings in Brazil
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
280
|
|
Top Free
|
|
407
|
|
Top Free
|
|
440
|
|
Top Free
|
|
480
|
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
NCCN Guidelines®
Clinical Guidelines
|
1
|
1 year ago | |
AAN Continuum Audio
|
1
|
3 years ago | |
HemeOncBuddy
hemeonc trials
|
0
|
9 months ago | |
ASTCT Practice Guidelines
|
0
|
4 months ago | |
CTCAE plus
Beyond paper-based management
|
0
|
4 months ago | |
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
|
0
|
2 months ago | |
ASCO Guidelines
|
0
|
7 months ago | |
Transplant (HCT) Guidelines
|
0
|
3 months ago | |
ASH Pocket Guides
|
0
|
4 months ago | |
ASCO-SEP®
ASCO Self-Evaluation Program
|
0
|
3 months ago |
Show More
Revenue and Downloads
Gain valuable insights into CARTOX performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent version
- 2.5 (1 year ago )
- Released on
- Jun 2, 2019 (5 years ago )
- Also available in
- United States, Mexico, Spain, Philippines, India, Italy, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Nigeria, Netherlands, Norway, New Zealand, Peru, Israel, Pakistan, Poland, Portugal, Romania, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Ukraine, Vietnam, South Africa, Germany, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, United Arab Emirates, Denmark, Dominican Republic, Algeria, Ecuador, Egypt, Finland, France, United Kingdom, Greece, Hong Kong, Hungary, Indonesia, Ireland, Czechia
- Last updated
- 2 months ago